top of page

Error message

success message

First-line treatment of massive PE

.

1

3 pts

Preferred imaging to evaluate for DPLD (be specific)

.

2

3 pts

FEV1/FVC ratio consistent with obstructive lung disease

.

3

3 pts

Medical therapies for loculated empyema

.

4

4 pts

First-line vasopressor for cardiogenic shock

.

5

4 pts

Most common genotype for alpha 1 antitrypsin deficiency

.

6

5 pts

Initial test when you suspect pulmonary hypertension

.

7

4 pts

Pleural fluid enzyme test for TB

.

8

5 pts

Definition of reversible airflow obstruction on PFT's

.

9

6 pts

Medication for aspirin-exacerbated respiratory disease

.

10

6 pts

Criteria for low-dose CT lung cancer screening

.

11

6 pts

Pleural fluid pH and glucose measurements that classify a complicated parapneumonic effusion

.

12

7 pts

ECMO machine parameter that controls CO2 removal

.

13

7 pts

One additional guideline-recommended medication option for severe COPD refractory to triple inhaler therapy to reduce exacerbations

.

14

10 pts

Emphysema pattern amenable to lung volume reduction surgery/intervention

.

15

14 pts

List the three most common causes of chronic cough

.

16

6 pts

List two things that provide mortality benefit in ARDS

.

17

7 pts

Peripheral eosinophil cutoff at which ICS should be considered in COPD

.

18

7 pts

Plateau pressure and tidal volume goals in ARDS

.

19

7 pts

Initial test for cystic fibrosis

.

20

7 pts

Describe the flow-volume loop for vocal cord dysfunction

.

21

7 pts

LABA that new GINA guidelines recommend (in addition to ICS) PRN as step 1 in asthma therapy

.

22

8 pts

Suspect this with asthma, eosinophilia, and moneuritis multiplex

.

23

8 pts

Two FDA approved treatments for IPF

.

24

9 pts

Initial imaging test to evaluate for CTEPH

.

25

9 pts

A large pneumothorax is >__cm at the apex

.

26

9 pts

List the five causes of hypoxemia

.

27

11 pts

List the berlin criteria (4)

.

28

12 pts

List Samter's triad (aspirin exacerbated respiratory disease)

.

29

14 pts

Patients with VTE should be anticoagulated for at least ___ (duration)

.

30

7 pts

Treatment for COP

.

31

7 pts

ILD associated with parietal pleural plaques

.

32

7 pts

List Light's criteria

.

33

9 pts

Monotherapy with ___ (inhaler) increases mortality in asthma patients

.

34

10 pts

Give one example of a condition that can cause normal FEV1, normal FVC, decreased DLCO on PFT's

.

35

11 pts

Next step for 6mm solid nodule in a heavy smoker

.

36

12 pts

Cheyne-Stokes breathing (central sleep apnea) is commonly associated with ___ (comorbidity), to which treatment should be directed

.

37

12 pts

Drug for prevention of high altitude sickness

.

38

12 pts

Name the five categories of pulmonary hypertension

.

39

12 pts

Apnea Hypopnea Index result that defines OSA (__ or more = OSA)

.

40

14 pts

Which type of scleroderma is more associated with ILD and what antibody is most associated with this type

.

41

15 pts

Name a smoking-related DPLD

.

42

16 pts

What are the components of lofgren's syndrome

.

43

18 pts

Cell pattern seen on BAL in HP

.

44

18 pts

What patients with pulmonary hypertension qualify for CCB therapy?

.

45

22 pts

bottom of page